Insights

Discover strategic insights from Vizient on biosimilar adoption, cost savings, interchangeability and formulary optimization in the evolving biologics market... read more

Explore how Vizient empowers pharmacy and health-system leaders with expert insights on infectious-disease pharmacotherapy—covering utilization trends, emerging treatments, drug-supply risk and formu... read more

The One Big Beautiful Bill (OBBB), passed this summer, contains a provision of great consequence for hospitals: Medicaid work requirements... read more

Non-clinical expenses can be the stuff of nightmares — but they don’t have to be … if you’re prepared. Here are five strategies to avoid your own horror story... read more

Fluency across clinical and financial perspectives is redefining leadership in healthcare... read more

A multi-part series exploring integration as a strategic, cultural and leadership discipline across all stages of organizational evolution. In this series, we will explore the ongoing, essential work... read more

How healthcare systems can act now to address the rising complexity, costs and capacity demands driven by an aging population... read more

As the dust settles following passage of the One Big Beautiful Bill Act (OBBB), the contours of a shifting healthcare landscape are taking shape. To succeed, organizations will need to balance the ne... read more

Telecom carriers nationwide are rapidly phasing out copper telephone lines. For hospitals and clinics still relying on legacy copper infrastructure — such as copper-based faxing, alarms, point-of-sal... read more

Explore how sustainability is reshaping healthcare delivery. Learn how health systems and suppliers are collaborating on climate action, supply chain reform, and responsible innovation to improve pat... read more

The OBBB introduces sweeping changes to Medicaid eligibility and financing, ACA tax credit eligibility and other provisions that, when taken together, are projected to decrease healthcare coverage an... read more

In the ongoing debate over healthcare costs, attention often centers on the price of drugs, hospital stays and payers. But behind the scenes, a quieter set of figures has been growing steadily: non-c... read more